Original Miltenyi Biotec 200-070-117 CliniMACS CD19 Reagent CE 7.5mL B Cell Depletion Reagent
Support Payment Term:
PayPal
USD
EUR
GBP
SGD
CNY
MXN
BRL
JPY
THB
AUD
$5885.71
Discover similar items
Page 1 of 2
Specifications for CliniMACS® CD19 Product Line
Overview
As a B cell lineage marker, CD19 is expressed from the early pro-B cell stage to the B cell lymphoblast stage; however, CD19 is down-regulated as B cells mature to plasma cells. The CD19 antigen is also expressed on most malignant B cells and on a subset of follicular dendritic cells.
The CliniMACS® CD19 Product Line consists of murine anti-CD19 monoclonal antibodies conjugated to superparamagnetic iron dextran particles.
One vial contains 7.5 mL sterile, non-pyrogenic solution.
The performance of the CliniMACS CD19 Product Line depends on the individual separation strategy. For information on respective capacities, refer to the CliniMACS User Manual or contact your local representative.
Please inquire about required CliniMACS System components and accessories.
